Effectiveness of mind-body therapies for sleep disturbance in older adults: a network meta-analysis.

GerontologistSep 10, 2026
Clinical ResearchGeriatrics

Zhongli Wang, Haoyu Yang, Fanghua Wang et al.

✦ AI-curated · Sources linked

In 30 seconds

This network meta-analysis evaluated the effectiveness of mind-body therapies for sleep disturbances in older adults, analyzing 45 studies with 3,568 participants. The results indicated that meditation, yoga, qigong, and tai chi significantly improved sleep quality compared to control, with meditation showing the greatest effect (MD: -3.49; 95% CrI: -4.92 to -2.09).

Key findings

  • Meditation improved sleep quality significantly more than control (MD: -3.49; 95% CrI: -4.92 to -2.09).
  • Yoga was associated with a mean difference of -2.40 in sleep quality (95% CrI: -4.55 to -0.27).
  • Qigong showed a mean difference of -2.21 in sleep quality (95% CrI: -4.01 to -0.42).
  • Meditation outperformed sleep hygiene education with a mean difference of -2.87 (95% CrI: -4.45 to -1.30).

Why it matters

Improving sleep quality in older adults is crucial for overall health and well-being. This analysis highlights effective non-pharmacological interventions, which can be integrated into treatment plans for managing sleep disturbances.

Source

PubMed · PMID 42576331

Published in Gerontologist. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Geriatrics

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.